J & J vaccine and Guillain-Barr é syndrome: Information on the FDA warning
Regulators and Yale experts say the benefits of receiving the vaccine still outweigh the risks, citing the rare chance of developing the neurological disorder.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Brain | Guillain-Barr Syndrome | Health | Neurology | Neuroscience | Science | Universities & Medical Training | Vaccines | Warnings | Yale